CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 188 of 1
Non-Antibody Products
Page 188 of 1,288
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| C2-8 | An inhibitor of polyQ aggregation (IC50s = 25 and 0.05 µM for recomb… | 1 mg | 21177-1 | More Info |
| C2-8 | An inhibitor of polyQ aggregation (IC50s = 25 and 0.05 µM for recomb… | 10 mg | 21177-10 | More Info |
| C2-8 | An inhibitor of polyQ aggregation (IC50s = 25 and 0.05 µM for recomb… | 25 mg | 21177-25 | More Info |
| C2-8 | An inhibitor of polyQ aggregation (IC50s = 25 and 0.05 µM for recomb… | 5 mg | 21177-5 | More Info |
| C29 | An inhibitor of TLR2 signaling; inhibits synthetic and bacterial TLR2 agon… | 1 mg | 27029-1 | More Info |
| C29 | An inhibitor of TLR2 signaling; inhibits synthetic and bacterial TLR2 agon… | 10 mg | 27029-10 | More Info |
| C29 | An inhibitor of TLR2 signaling; inhibits synthetic and bacterial TLR2 agon… | 25 mg | 27029-25 | More Info |
| C29 | An inhibitor of TLR2 signaling; inhibits synthetic and bacterial TLR2 agon… | 5 mg | 27029-5 | More Info |
| C3 | An inhibitor of MAO-B (IC50 = 0.021 µM); selective for MAO-B over MA… | 1 mg | 33166-1 | More Info |
| C3 | An inhibitor of MAO-B (IC50 = 0.021 µM); selective for MAO-B over MA… | 10 mg | 33166-10 | More Info |
| C3 | An inhibitor of MAO-B (IC50 = 0.021 µM); selective for MAO-B over MA… | 5 mg | 33166-5 | More Info |
| C527 | An inhibitor of the USP1 / UAF complex; inhibits USP1 / UAF deubiquitinase… | 10 mg | 21771-10 | More Info |
| C527 | An inhibitor of the USP1 / UAF complex; inhibits USP1 / UAF deubiquitinase… | 25 mg | 21771-25 | More Info |
| C527 | An inhibitor of the USP1 / UAF complex; inhibits USP1 / UAF deubiquitinase… | 5 mg | 21771-5 | More Info |
| C527 | An inhibitor of the USP1 / UAF complex; inhibits USP1 / UAF deubiquitinase… | 50 mg | 21771-50 | More Info |
| C53 | A STING agonist; activates human wild-type STING (EC50 = 185 nM), as well… | 1 mg | 37354-1 | More Info |
| C53 | A STING agonist; activates human wild-type STING (EC50 = 185 nM), as well… | 10 mg | 37354-10 | More Info |
| C53 | A STING agonist; activates human wild-type STING (EC50 = 185 nM), as well… | 5 mg | 37354-5 | More Info |
| C53 | A STING agonist; activates human wild-type STING (EC50 = 185 nM), as well… | 50 mg | 37354-50 | More Info |
| C646 | An inhibitor of the HAT p300 (IC50 = 1.6 µM); competitively binds p3… | 1 mg | 10549-1 | More Info |
| C646 | An inhibitor of the HAT p300 (IC50 = 1.6 µM); competitively binds p3… | 10 mg | 10549-10 | More Info |
| C646 | An inhibitor of the HAT p300 (IC50 = 1.6 µM); competitively binds p3… | 5 mg | 10549-5 | More Info |
| C-7280948 | A PRMT1 inhibitor (IC50 = 12.8 µM, in vitro) | 1 g | 21601-1 | More Info |
| C-7280948 | A PRMT1 inhibitor (IC50 = 12.8 µM, in vitro) | 100 mg | 21601-100 | More Info |
| C-7280948 | A PRMT1 inhibitor (IC50 = 12.8 µM, in vitro) | 250 mg | 21601-250 | More Info |
| C-7280948 | A PRMT1 inhibitor (IC50 = 12.8 µM, in vitro) | 500 mg | 21601-500 | More Info |
| C82 | An Mtb CdnP inhibitor (IC50 = 17.5 µM); selective for Mtb CdnP over… | 1 mg | 33563-1 | More Info |
| C82 | An Mtb CdnP inhibitor (IC50 = 17.5 µM); selective for Mtb CdnP over… | 10 mg | 33563-10 | More Info |
| C82 | An Mtb CdnP inhibitor (IC50 = 17.5 µM); selective for Mtb CdnP over… | 5 mg | 33563-5 | More Info |
| C-87 | An inhibitor of TNF-α; binds to TNF-α; inhibits TNF-α-in… | 10 mg | 36578-10 | More Info |
| C-87 | An inhibitor of TNF-α; binds to TNF-α; inhibits TNF-α-in… | 25 mg | 36578-25 | More Info |
| C-87 | An inhibitor of TNF-α; binds to TNF-α; inhibits TNF-α-in… | 5 mg | 36578-5 | More Info |
| C3001a | An activator of K2P2.1 / TREK1 and K2P10.1 / TREK2; increases current ampl… | 1 mg | 31064-1 | More Info |
| C3001a | An activator of K2P2.1 / TREK1 and K2P10.1 / TREK2; increases current ampl… | 10 mg | 31064-10 | More Info |
| C3001a | An activator of K2P2.1 / TREK1 and K2P10.1 / TREK2; increases current ampl… | 5 mg | 31064-5 | More Info |
| CA-074 | A selective cathepsin B inhibitor (Kis = 0.0087, 75, and 233 µM for… | 1 mg | 24679-1 | More Info |
| CA-074 | A selective cathepsin B inhibitor (Kis = 0.0087, 75, and 233 µM for… | 500 µg | 24679-500 | More Info |
| CA-4948 | An orally bioavailable inhibitor IRAK-4; has antitumor activity in ABC-typ… | 1 mg | 27598-1 | More Info |
| CA-4948 | An orally bioavailable inhibitor IRAK-4; has antitumor activity in ABC-typ… | 10 mg | 27598-10 | More Info |
| CA-4948 | An orally bioavailable inhibitor IRAK-4; has antitumor activity in ABC-typ… | 25 mg | 27598-25 | More Info |
| CA-4948 | An orally bioavailable inhibitor IRAK-4; has antitumor activity in ABC-typ… | 5 mg | 27598-5 | More Info |
| CA77.1 | An inducer of chaperone-mediated autophagy; induces the formation of autop… | 1 mg | 37300-1 | More Info |
| CA77.1 | An inducer of chaperone-mediated autophagy; induces the formation of autop… | 10 mg | 37300-10 | More Info |
| CA77.1 | An inducer of chaperone-mediated autophagy; induces the formation of autop… | 25 mg | 37300-25 | More Info |
| CA77.1 | An inducer of chaperone-mediated autophagy; induces the formation of autop… | 5 mg | 37300-5 | More Info |
| C14-A1 | An ionizable cationic lipid; has been used in the generation of LNPs; LNPs… | 1 mg | 40256-1 | More Info |
| C14-A1 | An ionizable cationic lipid; has been used in the generation of LNPs; LNPs… | 10 mg | 40256-10 | More Info |
| C14-A1 | An ionizable cationic lipid; has been used in the generation of LNPs; LNPs… | 5 mg | 40256-5 | More Info |
| Cabazitaxel | A semisynthetic taxane; stabilizes microtubule assembly by reducing lag ti… | 10 mg | 22262-10 | More Info |
| Cabazitaxel | A semisynthetic taxane; stabilizes microtubule assembly by reducing lag ti… | 25 mg | 22262-25 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile